News >

Navigating Treatment Algorithms in CLL

Caroline Seymour
Published: Tuesday, Jul 09, 2019

Rafic Farah, MD

Rafic Farah, MD

In chronic lymphocytic leukemia (CLL), the therapeutic armamentarium has undergone a drastic departure from chemotherapy-based regimens to those that are largely based on novel agents. In this new landscape, the guiding principles regarding which regimen to pursue are informed by a patient’s age, health, and mutational status.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: Advancing the Treatment of Bladder Cancers Using Evidence-Based Immuno-Oncology StrategiesJul 30, 20191.0
Medical Crossfire®: Where Are We Headed in the Treatment of Triple-Negative Breast Cancer?Jul 31, 20191.5
Publication Bottom Border
Border Publication